Protective effects of influenza vaccine in patients with coronary artery disease: a systematic review
DOI:
https://doi.org/10.33448/rsd-v11i9.31602Keywords:
Coronary artery disease; Disease prevention; Influenza vaccines.Abstract
Objective: To analyze the main protective effects of the influenza vaccine in patients with coronary artery disease. Methodology: This is a systematic review carried out using the PRISMA method, in the electronic databases PubMed, Scopus and Web of Science, using the following descriptors: “influenza vaccines”, “influenza”, “flu”, “coronary artery disease”, “myocardial infarction” and “acute coronary syndrome”. Full articles in Portuguese, English or Spanish published between January 2006 and December 2021 were included; studies that evaluated the effect of influenza vaccine in adult patients (≥18 years of age) with coronary artery disease; studies that included placebo or no vaccine as a control group; studies that reported at least one evaluated outcome and with statistical association. Results: 04 articles composed the final sample of this study. Regarding the approach of the articles found, it was found that three studies used the Randomized Clinical Trial, characterizing the studies as presenting a strong level of evidence (II). In all studies analyzed, influenza vaccine significantly reduced the risk of MACE (cardiovascular death, myocardial infarction, coronary revascularization) compared with the control group. Furthermore, in these studies the influenza vaccine reduced cardiovascular mortality and the risk of acute myocardial infarction. Conclusion: It was found that the influenza vaccine can significantly reduce cardiovascular events in patients with coronary artery disease.
References
Ahmad, F.B. & Anderson, R.N. (2021). The leading causes of death in the US for 2020. JAMA. 325, 1829-1830.
Barnes, M., Heywood, A.E., Mahimbo, A., Rahman, B., Newall, A.T. & Macintyre, C.R. (2015). Acute myocardial infarction and influenza: a meta-analysis of case-control studies. Heart. 101(21), 1738-1747.
Bauersachs, R., Zeymer, U., Brière, J.B., Marre, C., Bowrin, K. & Huelsebeck M. (2019). Burden of Coronary Artery Disease and Peripheral Artery Disease: A Literature Review. Cardiovasc Ther. 2019, 8295054.
Brasil. Ministério da Saúde (MS). (1998). Lei no 9.610, de 19 de fevereiro de 1998, que altera, atualiza e consolida a legislação sobre direitos autorais e dá outras providências. Diário Oficial da União. Brasília: Ministério da Saúde. Recuperado de http://www.planalto.gov.br/ccivil_03/leis/l9610.htm
Ciszewski, A., Bilinska, Z.T., Brydak, L.B., Kepka, C., Kruk, M., Romanowska, M., et al. (2008). Influenza vaccination in secondary prevention from coronary ischaemic events in coronary artery disease: FLUCAD study. Eur Heart J. 29, 1350-1358.
Corrales-Medina, V.F., Madjid, M. & Musher, D.M. (2010). Role of acute infection in triggering acute coronary syndromes. Lancet Infect. Dis. 10, 83–92.
Corrales-Medina, V.F., Suh, K.N., Rose, G., Chirinos, J.A., Doucette, S., Cameron, D.W., et al. (2011). Cardiac complications in patients with community-acquired pneumonia: a systematic review and meta-analysis of observational studies. PLoS Med. 8, e1001048.
Chacko, B., Peter, J.V., Pichamuthu, K., Ramakrishnna, K., Moorthy, M., Karthik, R., et al. (2012). Cardiac manifestations in patients with pandemic (H1N1) 2009 virus infection needing intensive care. J Crit Care. 27(1), 106.e1-6.
Chiang, M.H., Wu, H.H., Shif, C.J., Chen Y.T., Kuo, S.C. & Chen, T.L. (2017). Association between influenza vaccination and reduced risks of major adverse cardiovascular events in elderly patients. Am Heart J. 193, 1-7.
Fink, G., Orlova-Fink, N., Schindler, T., Grisi, S., Ferrer, A.P.S., Daubenberger, C., et al. (2020). Inactivated trivalent influenza vaccination is associated with lower mortality among patients with COVID-19 in Brazil. BMJ Evid Based Med. 26(4), 1-8.
Fokkema, M.L., James, S.K., Albertsson, P., Akerblom, A., Calais, F., Eriksson, P., et al. (2013). Population trends in percutaneous coronary intervention: 20-year results from the SCAAR (Swedish Coronary Angiography and Angioplasty Registry). J Am Coll Cardiol. 61, 1222–1230.
Fountoulaki, K., Tsiodras, S., Polyzogopoulou, E., Olympios, C. & Parissis, J. (2018). Beneficial effects of vaccination on cardiovascular events: myocardial infarction, stroke heart failure. Cardiology. 141, 98–106.
Gurfinkel, E.P., de la Fuente, R.L., Mendiz, O. & Mautner, B. (2004). Flu vaccination in acute coronary syndromes and planned percutaneous (FLUVACS) study - one-year follow-up. Eur Heart J. 25, 25-31.
Harskamp, R.E. & van Ginkel, M.W. (2008). Acute respiratory tract infections: a potential trigger for the acute coronary syndrome. Ann Med. 40, 121-128.
Hsu, S-Y., Chen, F-L., Liaw, Y-P., Huang, J-Y., Nfor, O.N. & Chao, D-Y. (2016). A matched influenza vaccine strain was effective in reducing the risk of acute myocardial infarction in elderly persons: a population-based study. Medicine. 95(10), e2869.
Jamal, A., Phillips, E., Gentzke, A.S., Homa, D.M., Babb, S.D., King, B.A., et al. (2018). Current Cigarette Smoking Among Adults - United States, 2016. MMWR Morb Mortal Wkly Rep. 67(2), 53-59.
Kwong, J.C., Schwartz, K.L., Campitelli, M.A., Chung, H., Crowcroft, N.S., Karnauchow, T., et al. (2018). Acute myocardial infarction after laboratory-confirmed influenza infection. N Engl J Med. 378, 345-353.
Liu, R., Liu, X., Yang, P., Du, X., He, L., Chen, T., et al. (2020). Influenza-associated cardiovascular mortality in older adults in Beijing, China: a population-based time-series study. BMJ Open. 10(11), e042487.
Macintyre, C.R., Heywood, A.E., Kovoor, P., Ridda, I., Seale, H., Tan, T., et al. (2013). Ischaemic heart disease, influenza and influenza vaccination: a prospective case control study. Heart. 99(24), 1843-1848.
Macintyre, C.R., Mahimbo, A., Moa, A.M. & Barnes, M. (2016). Influenza vaccine as a coronary intervention for prevention of myocardial infarction. Heart. 102, 1953–1956.
Mameli, C., Cocchi, I., Fumagalli, M. & Zuccotti, G. (2019). Influenza vaccination: effectiveness, indications and limits in the pediatric population. Front. Pediatr. 7, 317.
Moher, D., Shamseer, L., Clarke, M.; Ghersi, D., Liberati, A., Petticrew, M., et al (2015). Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst. Rev. 4(1), 1-9.
Nascimento, J.W.A., Santos, R.S., Santos, T.M.R., Silva, A.L.B., Rodrigues, L.D.C., Silva, V.W., et al. (2021). Complications associated with intimate partner violence in pregnant women: a systematic review. Int. J. Dev. Res. 11(7), 48924-48928.
Natarajan, P. & Cannon, C.P. (2011). Myocardial infarction vaccine? Evidence supporting the influenza vaccine for secondary prevention. Eur Heart J. 32, 1701-1703.
Pati, D. & Lorusso, L.N. (2018). How to Write a Systematic Review of the Literature. HERD. 11(1), 15-30.
Phrommintikul, A., Kuanprasert, S., Wongcharoen, W., Kanjanavanit, R., Chaiwarith, R. & Sukonthasarn, A. (2011). Influenza vaccination reduces cardiovascular events in patients with acute coronary syndrome. Eur Heart J. 32(14), 1730-1735.
Ricoca Peixoto, V., Vieira, A., Aguiar, P., Sousa, P., Carvalho, C., Thomas, D., et al. (2021). Determinants for hospitalisations, intensive care unit admission and death among 20,293 reported COVID-19 cases in Portugal, March to April 2020. Euro Surveill. 26(33), 1-10.
Siriwardena, A.N., Gwini, S.M. & Coupland, C.A. (2010). Influenza vaccination, pneumococcal vaccination and risk of acute myocardial infarction: matched case-control study. CMAJ. 182, 1617–1623.
Stillwell, S., Fineout-Overholt, E., Melnyk, B.M. & Wiliamson, K.M. (2010). Evidence– based practice: step by step. Am J Nurs; 110(5), 41-47.
Vardeny, O. & Solomon, S.D. (2017). Influenza vaccination: a one-shot deal to reduce cardiovascular events. Eur. Heart J. 38, 334–337.
Wu, H.H., Chang, Y.Y., Kuo, S.C. & Chen, Y.T. (2019). Influenza vaccination and secondary prevention of cardiovascular disease among Taiwanese elders-a propensity score-matched follow-up study. PLoS ONE. 14(7), e0219172.
Yedlapati, S.H., Khan, S.U., Talluri, S., Lone, A.N., Khan, M.Z., Khan, M.S., et al. (2021). Effects of influenza vaccine on mortality and cardiovascular outcomes in patients with cardiovascular disease: a systematic review and meta-analysis. J Am Heart Assoc. 10, e019636.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Emanuel de Freitas Correia; Geny Vitória Albuquerque Gomes; Yasmim Lustosa Zaidan; Jaíne Arruda Melo; Vinícius Souza Melo; José William Araújo do Nascimento
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
